Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center
Background. Cavernous hemangioma is a rare benign tumor that develops from the adrenal glands. In this study, we present our experience with patients with adrenal cavernous hemangiomas (ACH) in a Chinese population. Methods. Demographic, diagnostic, surgical, and pathological findings in patients at...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2021/5549925 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832550594068348928 |
---|---|
author | Henghai Huang Xiaoyun Wu Xiaocao Lin Delin Li Jingjing Zeng |
author_facet | Henghai Huang Xiaoyun Wu Xiaocao Lin Delin Li Jingjing Zeng |
author_sort | Henghai Huang |
collection | DOAJ |
description | Background. Cavernous hemangioma is a rare benign tumor that develops from the adrenal glands. In this study, we present our experience with patients with adrenal cavernous hemangiomas (ACH) in a Chinese population. Methods. Demographic, diagnostic, surgical, and pathological findings in patients at a single institution who were adrenalectomized as a result of ACH were retrospectively reviewed. Results. Among 601 patients who underwent adrenalectomy, 8 (1.33%; 5 men, 3 women) cases were diagnosed with ACH between January 1, 1998, and December 31, 2018, in a single institution. The mean age was 53.25 ± 11.9 years (range, 35–67 years). Four (50%) were asymptomatic, and three (37.5%) complained of abdominal or flank discomfort. Preoperative computed tomography (CT) revealed ACH in 3 (37.5%) cases. Well-defined borders and heterogeneous enhancement with characteristic progressive partial filling-in were characteristic CT features of ACH (tumor size>3 cm). The mean tumor size was 5.16 ± 3.4 cm (range, 1.5–11 cm). No recurrence occurred during a median follow-up period of 38.37 months (range, 8–60 months). Conclusions. ACH was asymptomatic in most cases, and diagnosis could be challenging. Adrenalectomy is a safe treatment modality for ACH, and it ensures favorable outcomes. |
format | Article |
id | doaj-art-e31ccf60b6d440b0ac2ae851018dda8b |
institution | Kabale University |
issn | 1687-8337 1687-8345 |
language | English |
publishDate | 2021-01-01 |
publisher | Wiley |
record_format | Article |
series | International Journal of Endocrinology |
spelling | doaj-art-e31ccf60b6d440b0ac2ae851018dda8b2025-02-03T06:06:28ZengWileyInternational Journal of Endocrinology1687-83371687-83452021-01-01202110.1155/2021/55499255549925Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single CenterHenghai Huang0Xiaoyun Wu1Xiaocao Lin2Delin Li3Jingjing Zeng4Department of Urology, Wuzhou GongRen Hospital, Wuzhou, GuangXi, ChinaDepartment of Nursing, GuangXi Medical College, Nanning, GuangXi, ChinaDepartment of Urology, Wuzhou GongRen Hospital, Wuzhou, GuangXi, ChinaDepartment of Urology, Wuzhou GongRen Hospital, Wuzhou, GuangXi, ChinaDepartment of Pathology, The First Affliated Hospital of GuangXi Medical University, Nanning, GuangXi, ChinaBackground. Cavernous hemangioma is a rare benign tumor that develops from the adrenal glands. In this study, we present our experience with patients with adrenal cavernous hemangiomas (ACH) in a Chinese population. Methods. Demographic, diagnostic, surgical, and pathological findings in patients at a single institution who were adrenalectomized as a result of ACH were retrospectively reviewed. Results. Among 601 patients who underwent adrenalectomy, 8 (1.33%; 5 men, 3 women) cases were diagnosed with ACH between January 1, 1998, and December 31, 2018, in a single institution. The mean age was 53.25 ± 11.9 years (range, 35–67 years). Four (50%) were asymptomatic, and three (37.5%) complained of abdominal or flank discomfort. Preoperative computed tomography (CT) revealed ACH in 3 (37.5%) cases. Well-defined borders and heterogeneous enhancement with characteristic progressive partial filling-in were characteristic CT features of ACH (tumor size>3 cm). The mean tumor size was 5.16 ± 3.4 cm (range, 1.5–11 cm). No recurrence occurred during a median follow-up period of 38.37 months (range, 8–60 months). Conclusions. ACH was asymptomatic in most cases, and diagnosis could be challenging. Adrenalectomy is a safe treatment modality for ACH, and it ensures favorable outcomes.http://dx.doi.org/10.1155/2021/5549925 |
spellingShingle | Henghai Huang Xiaoyun Wu Xiaocao Lin Delin Li Jingjing Zeng Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center International Journal of Endocrinology |
title | Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center |
title_full | Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center |
title_fullStr | Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center |
title_full_unstemmed | Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center |
title_short | Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center |
title_sort | clinical features and outcomes of adrenal cavernous hemangioma a study of 8 cases from a single center |
url | http://dx.doi.org/10.1155/2021/5549925 |
work_keys_str_mv | AT henghaihuang clinicalfeaturesandoutcomesofadrenalcavernoushemangiomaastudyof8casesfromasinglecenter AT xiaoyunwu clinicalfeaturesandoutcomesofadrenalcavernoushemangiomaastudyof8casesfromasinglecenter AT xiaocaolin clinicalfeaturesandoutcomesofadrenalcavernoushemangiomaastudyof8casesfromasinglecenter AT delinli clinicalfeaturesandoutcomesofadrenalcavernoushemangiomaastudyof8casesfromasinglecenter AT jingjingzeng clinicalfeaturesandoutcomesofadrenalcavernoushemangiomaastudyof8casesfromasinglecenter |